Immunotherapy--A Powerful Tool in the Fight Against CancerShockney, Lillie D.Journal of Oncology Navigation & Survivorship
In the meantime, more studies are being launched on immunotherapy as a treatment for oral and anal cancers that, likecervical cancer, are caused by the human papillomavirus (HPV). When it comes to melanoma, as well as kidney and lung cancer, a new kind of drug that blocks a protein calle...
Immunotherapy is a promising new form of cancer treatment, but the supercharged immune cells it employs can become exhausted in the fight. Researchers in Japan have found a way to keep them going for longer, by rejuvenating them with stem cells. Our immune systems are our most powerful tools ...
Researchers at the University of Montreal Hospital Research Centre (CRCHUM) have shown that immunotherapy treatments against cancer could reduce the amount of virus that persists in people on triple therapy. In a study published in the journalNature Communications, they show, in the cells of people...
Aiming to increase efficacy of surgical solutions and patient outcome, immunotherapy for rare cancers is becoming a more viable option, providing much-needed hope and treatments for patients. With this study and others, immunotherapy is poised to transform rare cancer treatment and provide hope for ...
one that responds well to both immunotherapy and targeted therapy, which applies substances aimed at specific cancer cells; the otherresistant to both these treatment types. “With this system, we could closely compare responsive to resistant tumors, helping us figure out the key factors that deter...
improves the function of immune system cells along with all other cells in the body. This will enable the immune system to better fight cancer. Also, the instructions direct the immune system to eliminate cancer from the body. These instructions activate the immune system response against cancer....
neoantigens. “Cancer is like a person’s thumbprint; each person’s cancer is uniquely theirs,” says Bill Hearl, CEO of Immunomic Therapeutics, a clinical stage biotechnology company developing a nucleic acid immunotherapy platform with the potential to treat cancer, allergies and animal health ...
“Cancer immunotherapy has come a long way over the past decade, but its impact for patients has been limited due to a scarcity of targets and the complex immunosuppressive nature of the TME,” said Al-Hajj. “At IO Biotech we are focused on changing the paradigm through a diverse portfolio...
Just as with immunotherapy vaccines, oncolytic viral therapy can create a long-term, robust defense that trains theimmune systemto attack cancer over months, or even years. Current work at the OSUCCC-Jamesusing oncolytic virusestakes advantage of three categories of treatment – a virus, a cancer...